| Literature DB >> 35012115 |
Khaled M Hosny1, Hala M Alkhalidi2, Waleed S Alharbi1, Shadab Md1, Amal M Sindi3, Sarah A Ali3, Rana B Bakhaidar1, Alshaimaa M Almehmady1, Eman Alfayez4, Mallesh Kurakula5.
Abstract
Natural polymers are revolutionizing current pharmaceutical dosage forms design as excipient and gained huge importance because of significant influence in formulation development and drug delivery. Oral health refers to the health of the teeth, gums, and the entire oral-facial system that allows us to smile, speak, and chew. Since years, biopolymers stand out due to their biocompatibility, biodegradability, low toxicity, and stability. Polysaccharides such as cellulose and their derivatives possess properties like novel mechanical robustness and hydrophilicity that can be easily fabricated into controlled-release dosage forms. Cellulose attracts the dosage design attention because of constant drug release rate from the precursor nanoparticles. This review discusses the origin, extraction, preparation of cellulose derivatives and their use in formulation development of nanoparticles having multidisciplinary applications as pharmaceutical excipient and in drug delivery, as bacterial and plant cellulose have great potential for application in the biomedical area, including dentistry, protein and peptide delivery, colorectal cancer treatment, and in 3D printable dosage forms.Entities:
Keywords: biopolymers; cellulose derivatives; controlled release; drug delivery; excipient; nanoparticles
Year: 2021 PMID: 35012115 PMCID: PMC8747402 DOI: 10.3390/polym14010092
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Schematic representation of β 1,4 glycoside linkage in glucose units.
Figure 2Schematic representation of preparation of different allomorphic forms of cellulose.
Figure 3Scheme representing extraction of cellulose from palm kernel cake.
Illustration of physiochemical properties of different cellulose derivatives.
| Name | Ethyl Cellulose | Hydroxyl Propyl Cellulose (HPC) | Methyl Cellulose | Hydroxyl Propyl Methyl Cellulose (HPMC) | Carboxy Methyl Cellulose (CMC) | Sodium Carboxy Methyl Cellulose |
|---|---|---|---|---|---|---|
| Chemical |
|
|
|
|
|
|
| Molecular weight | 454.513 g/mol | average Mn ~10,000 g/mol | 454.513 g/mol | 1261.45 g/mol | 180.15588 g/mol | 262.19 g/mol |
| Viscosity | 5% in toluene/ethanol 80:20(lit.) is 46 cP. | The value of [η] decreases strongly with increasing temperature | 2% of solution in water at 25 °C is | 2% of solution in water at 25 °C is | 2 % of solution in water at 25 °C is 400–800 cP. | 1 % of solution in water at 25 °C is 1500–3000 cP. |
| Solubility | Practically insoluble in water | Soluble in water, methyl alcohol, ethyl alcohol | Soluble in water | Soluble in water 50 mg/mL | Soluble in water 20 mg/mL | Soluble in water 10 mg/mL |
| Use | Ethyl cellulose is used as a food additive and stabilizer for all animal feeds (Bampidis et al., 2020) and as an emulsifier [ | It is used as an excipient, and topical ophthalmic protectant, solubility enhancer used for nanosuspensions, amorphous solid dispersions and poorly soluble drugs, and lubricant. | Bulk forming laxatives, artificial tears products [ | Excipient in high speed tableting and capsule formulations. | Used as viscosity modifiers; Emulsion stabilizer of injections; Adhesion and film-forming agents of tablets [ | Used as a thickening agent Dispersion, emulsification, suspension, protective colloid [ |
Figure 4Structural organization of bacterial cellulose. A general overview (Courtesy Suleva et al., 2015). Characterization of bacterial cellulose (BC) or regenerated BC (RBC) based drug delivery.
Various characterization conducted for BC or RBC based drug delivery systems.
| S. No | Parameters/Characterizations | Intention of Analysis |
|---|---|---|
| 1 | FTIR | To determine the effects of various ingredients (like BC or RBC) on the purity of model drug |
| 2 | PXRD | To determine the crystallinity of BC or RBC based drugs |
| 3 | SEM | To evaluate the surface morphology of BC or RBC based drug delivery systems |
| 4 | DSC | To evaluate the interaction between BC or RBC and model drug |
| 5 | TGA | To analyze the thermo-stability of BC or RBC based drug delivery system |
| 6 | Loading efficiency | To check the percent drug loading of matrices/composites prepared BC or RBC |
| 7 | Release study | To check the release of model drug from BC or RBC based matrices or composites. |
| 8 | Release kinetics | To evaluate the mechanism of release like zero order, 1st order or pseudo order, fickian and non fickian behavior |
| 9 | Thickness | Drug matrices prepared with BC or RBC are subjected for thickness evaluation using vernier caliper. |
| 10 | Friability | To determine the withstanding power of prepared matrices based on BC or RBC. |
Examples of cellulose polymers used in the oral delivery of peptides and proteins.
| Cellulose Polymer Used | Oral Delivery System | Peptide or Protein Used | Reference |
|---|---|---|---|
| Ethyl cellulose a, Hydroxypropyl methylcellulose phthalate a | Gastrointestinal mucoadhesive patch system (GI-MAPS) | G-CSF | [ |
| Hydroxypropyl methyl cellulose a,b | Pulsatile drug delivery systems (PDDS) | Insulin | [ |
| Hydroxypropyl methylcellulose phthalate a | Chitosan-based polymeric nanoparticles | Insulin | [ |
| Sodiumcarboxy methylcellulose b | Polymer-inhibitor conjugates | Insulin | [ |
| Cellulose acetate a | Gastro-intestinal patch system (GI-PS) | Erythropoietin | [ |
| Sodiumcarboxy methylcellulose b | Pepstatin-matrix conjugate | Pepstatin A | [ |
| Carboxymethyl cellulose b | Crosslinked alginate–carboxymethyl cellulose beads | Albumin | [ |
a providing protection against acidic conditions. b providing mucoadhesive properties.
Examples of cellulose derivatives used by 3D printing for oral applications.
| Dosage Form | Cellulose Type | Application | 3D Printing Technique | Reference |
|---|---|---|---|---|
| 3D printed Tablets | HPMC | To optimize viscosity and to control the release | Extrusion printing | [ |
| 3D printed Tablets | HPC | to accelerate tablet disintegration and drug release. | Fused deposition modelling (FDM) 3D printing | [ |
| 3D-printed swellable/erodible capsular device | HPC | To create erodible capsular device for pulsatile oral application | Fused deposition modelling (FDM) 3D printing | [ |
| immediate release (IR) 3D-printed oral dosage forms | HPC | To develop formulations industrially relevant | Fused deposition modelling (FDM) 3D printing | [ |
| Oral tablets | EC | To develop adjustable dissolution behavior based on selective laser sintering technique | Selective laser sintering (SLS) 3D printing | [ |
| Oral tablets | cellulose nanocrystals (CNCs) | Used as support materials for printing | droplet-based freeform 3D printing | [ |
| Oral tablets | HPMC, HPC, EC | To investigate the effect of cellulose filaments on in-vitro drug release performance | Hot melt extrusion (HME) 3D printing | [ |
HPMC: Hydroxypropyl methylcellulose; HPC: Hydroxypropyl cellulose; EC: Ethyl cellulose; FDM: Fused deposition modelling; SLS: Selective laser sintering; CNC: Cellulose nanocrystals; HME: Hot melt extrusion.